Catherine Roche-Lestienne

发表

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment.

Claude Preudhomme, Pierre Fenaux, C. Preudhomme, 2002, Blood.

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

Claude Preudhomme, Philippe Rousselot, A. Vekhoff, 2010, The New England journal of medicine.

Mutations in the ABL kinase domain pre-exist the onset of imatinib treatment.

Claude Preudhomme, C. Preudhomme, C. Roche-Lestienne, 2003, Seminars in hematology.